⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.
about
Prostate-specific membrane antigen as a target for cancer imaging and therapySynthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry.[(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.PET imaging in prostate cancer: focus on prostate-specific membrane antigenPSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseasePET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.Metal-Based PSMA Radioligands.Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing.Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.Design, Synthesis, and Evaluation of a Neurokinin-1 Receptor-Targeted Near-IR Dye for Fluorescence-Guided Surgery of Neuroendocrine Cancers.Radiochemistry and Preclinical PET Imaging of 68Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen.Dendrimer-based contrast agents for PET imaging.Convenient Preparation of [(68)Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy.Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.The role of the capping bond effect on pyclen natY3+/90Y3+ chelates: full control of the regiospecific N-functionalization makes the difference
P2860
Q26799439-83814AE8-504A-4685-A896-A631EE937289Q33700114-4490CF0A-4975-4C85-AC33-9A02065AAEE9Q35877470-DFCBE2C5-0C35-447E-8F8D-AAD32FA77DD7Q36363280-B3A9115D-C672-42FD-A787-8378688474E9Q36867784-51F2392F-8E07-42AA-B681-49516D53F99DQ37390681-CF7397F8-F12A-4AF2-9C76-AD0195591CB6Q37594922-44F33D1E-596E-4A10-87EE-8868AD9A3DE7Q37623394-983BF31F-5B80-4DF6-AE71-C5E25E61BE66Q37636649-4811C68C-0D6F-439C-BF96-E179DFBA767EQ38099369-AEE06CF5-FC83-42A0-99CC-7080C9C44688Q38808957-EBDC0BF1-2794-49B4-8C92-CF70ADAC6529Q38820744-92FBE68E-E1F9-4B00-AFF5-668756F91C88Q38831232-C4FD8C58-080C-4F65-85A3-DE83960D5258Q38846349-816ABD8E-31CB-4C98-9468-4C8E6D07082DQ38876206-1D4D2FDC-4E02-42F8-BDDD-F17D90B0599DQ39198527-8AA79DF8-A2D4-403A-8E21-DB9DADDA62EAQ39710843-6A8E042A-2F64-4F75-8094-EC2849648413Q39869574-43B91185-7937-4810-888E-4276440A774AQ41131993-61722548-93A7-464A-BC08-F5AD0C7A5D56Q41704211-86C13DB4-C5C3-45F8-8041-647BAC0FC5A9Q45753373-1B8584D7-DC45-4D47-BDC0-61E6A2311C7BQ47362426-D748AF67-D960-4355-8C53-7F98179BE82EQ51440427-3B11125A-2ABA-413A-8264-0187ACBD4012Q53676991-98B32A8F-BD79-48DB-9C3B-CFD9637CAAD9Q58931428-D3F0B36E-939D-4B60-B554-41DA396D4D7E
P2860
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
⁶⁴Cu-labeled inhibitors of pro ...... ET imaging of prostate cancer.
@en
type
label
⁶⁴Cu-labeled inhibitors of pro ...... ET imaging of prostate cancer.
@en
prefLabel
⁶⁴Cu-labeled inhibitors of pro ...... ET imaging of prostate cancer.
@en
P2093
P2860
P356
P1476
⁶⁴Cu-labeled inhibitors of pro ...... ET imaging of prostate cancer.
@en
P2093
Catherine A Foss
Martin G Pomper
Mrudula Pullambhatla
Riccardo Ferdani
Ronnie C Mease
Sangeeta Ray Banerjee
P2860
P304
P356
10.1021/JM401921J
P407
P577
2014-03-07T00:00:00Z